Skip to main content
. 2017 Jan 17;6(1):e004699. doi: 10.1161/JAHA.116.004699

Table 1.

Baseline Demographics and Patient Characteristics by History of PAD

Variable PAD (n=884) No PAD (n=17 096) P Value
Age, y, median (25th, 75th) 73 (66.5, 79) 70 (62, 76) <0.0001
Female sex 251/884 (28.4) 6090/17 096 (35.6) <0.0001
Region <0.0001
North America 307/884 (34.7) 4133/17 096 (24.2)
Latin America 138/884 (15.6) 3299/17 096 (19.3)
Europe 368/884 (41.6) 6893/17 096 (40.3)
Asia Pacific 71/884 (8.0) 2771/17 096 (16.2)
CHADS2 score, mean±SD 2.66±1.25 2.09±1.09 <0.0001
≤1 164/884 (18.6) 5929/17 096 (34.7)
2 284/884 (32.1) 6152/17 096 (36.0)
≥3 436/884 (49.3) 5015/17 096 (29.3)
Presenting characteristics
Systolic BP, mm Hg, median (25th, 75th) 130 (120, 140) 130 (120, 140) 0.2785
Weight, kg, median (25th, 75th) 83.0 (71.5, 95.8) 82.0 (70.0, 95.5) 0.1417
Moderate or severe renal impairment 228/884 (25.8) 2745/17 021 (16.1) <0.0001
Baseline comorbidities
History of stroke, TIA, or systemic embolism 295/884 (33.4) 3189/17 096 (18.7) <0.0001
Carotid disease (bruit, stent, stenosis, endarterectomy) 169/884 (19.1) 441/17 096 (2.6) <0.0001
Nonparoxysmal AF type 745/884 (84.3) 14 470/17 093 (84.7) 0.7609
Prior warfarin/VKA 553/884 (62.6) 9721/17 096 (56.9) 0.0008
Coronary artery disease 523/884 (59.2) 5469/17 092 (32.0) <0.0001
Myocardial infarction 257/884 (29.1) 2297/17 094 (13.4) <0.0001
CHF within 3 months or LVEF ≤40% 363/884 (41.1) 6000/17 096 (35.1) 0.0003
Diabetes mellitus 325/884 (36.8) 4172/17 096 (24.4) <0.0001
Hypertension 813/884 (92.0) 14 991/17 096 (87.7) 0.0001
Current smoking 89/884 (10.1) 1378/17 079 (8.1) 0.0343
Moderate or worse valvular heart disease 239/884 (27.0) 2953/17 094 (17.3) <0.0001
History of bleeding 213/884 (24.1) 2794/17 093 (16.3) <0.0001
History of fall within previous year 77/828 (9.3) 669/15 451 (4.3) <0.0001
Medications
ACEI or ARB 668/877 (76.2) 12 053/16 817 (71.7) 0.0039
Beta blocker 603/877 (68.8) 10 767/16 817 (64.0) 0.0044
Aspirin 345/884 (39.0) 5231/17 096 (30.6) <0.0001
Clopidogrel 33/884 (3.7) 300/17 096 (1.8) <0.0001

ACEI indicates angiotensin‐converting enzyme inhibitor; AF, atrial fibrillation; ARB, angiotensin receptor blocker; BP, blood pressure; CHF, congestive heart failure; LVEF, left ventricular ejection fraction; PAD, peripheral artery disease; TIA, transient ischemic attack; VKA, vitamin K antagonist.